GO:0051800 phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051800 describes the enzymatic removal of the 3-phosphate from phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2], producing phosphatidylinositol-4-phosphate [PI(4)P] and inorganic phosphate.
• PTEN is the canonical enzyme with this activity, and it directly dephosphorylates PI(3,4)P2 to terminate PI3K signaling.
• Other enzymes, including voltage-sensing phosphatases (VSPs) and inositol polyphosphate 4-phosphatase II (INPP4B), also regulate PI(3,4)P2 levels, though through distinct catalytic mechanisms [1,5].
• PI(3,4)P2 is a key lipid second messenger that recruits effector proteins to control cell survival, proliferation, and migration [2,4].
• Dysregulation of this activity is linked to cancer, chemoresistance, and immune disorders [4,5,6].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the specific roles of enzymes with this activity in health and disease.
Description
Phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity (GO:0051800) is a molecular function that catalyzes the hydrolysis of phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] to phosphatidylinositol-4-phosphate [PI(4)P] and phosphate. This reaction is a critical node in phosphoinositide signaling, directly opposing the action of class I phosphoinositide 3-kinases (PI3Ks) that generate PI(3,4)P2 and its derivative PI(3,4,5)P3. By removing the 3-phosphate, this activity helps terminate PI3K-driven signals that promote cell growth, survival, and metabolism. The most well-known enzyme carrying this activity is PTEN, a tumor suppressor frequently mutated in human cancers. However, other enzymes such as voltage-sensing phosphatases (VSPs) and inositol polyphosphate 4-phosphatase II (INPP4B) also influence PI(3,4)P2 levels, albeit through different catalytic mechanisms [1,5]. Understanding GO:0051800 is therefore essential for researchers studying lipid signaling, cancer biology, and cellular regulation.
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity At A Glance
| GO ID | GO:0051800 |
|---|---|
| GO term | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity |
| Ontology | molecular_function |
| Synonym | PTEN activity |
| Definition | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + H2O = 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate. |
| Major function | Dephosphorylation of PI(3,4)P2 at the 3-position to terminate PI3K signaling. |
| Substrate | Phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] |
| Product | Phosphatidylinositol-4-phosphate [PI(4)P] and phosphate |
| Cellular process | Phosphoinositide metabolism and signal transduction |
What Is GO:0051800?
In my own words, GO:0051800 refers to the enzymatic activity that removes the phosphate group at the 3-position of the inositol ring of phosphatidylinositol-3,4-bisphosphate, using water to cleave the bond and releasing phosphate. This reaction converts PI(3,4)P2 into PI(4)P, thereby directly reducing the cellular pool of this signaling lipid.
Why Is phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity Important in Cell Biology?
GO:0051800 is important because it directly controls the cellular levels of PI(3,4)P2, a lipid second messenger that recruits and activates proteins containing pleckstrin homology (PH) domains, such as Akt, to drive cell survival and proliferation. By dephosphorylating PI(3,4)P2, enzymes with this activity act as brakes on PI3K signaling, and their loss leads to hyperactivation of downstream pathways that contribute to cancer and other diseases. Moreover, the balance between PI(3,4)P2 production and degradation is crucial for normal development and immune function, making this activity a focal point for therapeutic intervention [2,6].
• Regulates PI3K signaling by removing the 3-phosphate from PI(3,4)P2, thereby limiting Akt activation.
• PTEN, the canonical enzyme with this activity, is one of the most frequently mutated tumor suppressors in human cancers.
• Loss of this activity leads to accumulation of PI(3,4)P2 and PI(3,4,5)P3, promoting uncontrolled cell growth.
• INPP4B, which also regulates PI(3,4)P2 levels, is associated with chemoresistance and poor outcome in acute myeloid leukemia.
• SHIP1 and SHIP2 modulate PI(3,4)P2 indirectly by dephosphorylating PI(3,4,5)P3, affecting immune cell signaling [2,6].
• Voltage-sensing phosphatases exhibit 3-phosphatase activity toward PI(3,4)P2, linking membrane voltage to lipid signaling [1,7].
• This activity is essential for proper neuronal and immune cell function, as shown in transgenic mouse models.
• Dysregulation of PI(3,4)P2 metabolism is implicated in cancer, diabetes, and immunological disorders [2,4,5].
• Understanding this activity aids in the development of targeted therapies that modulate phosphoinositide signaling.
• CRISPR-based editing of genes encoding these enzymes enables precise functional studies in disease models.
Molecular Mechanism of phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs the lipid PI(3,4)P2 and positions it for modification.
Enzymes with this activity, such as PTEN, contain a catalytic domain that specifically binds phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] within the membrane. The binding involves electrostatic interactions between basic residues in the enzyme and the negatively charged phosphate groups of the lipid. This substrate specificity ensures that only PI(3,4)P2, and not other phosphoinositides, is dephosphorylated at the 3-position.
Catalytic dephosphorylation
In simple terms: The enzyme uses water to cut off the 3-phosphate, turning PI(3,4)P2 into PI(4)P.
The catalytic mechanism involves a nucleophilic attack by water on the phosphate group at the 3-position of the inositol ring. This reaction is facilitated by a conserved cysteine residue in the active site of PTEN, which acts as a nucleophile to form a phosphoenzyme intermediate, followed by hydrolysis to release phosphate and produce phosphatidylinositol-4-phosphate [PI(4)P]. The reaction is highly specific and requires the presence of the 3-phosphate on the substrate.
Product release and membrane dissociation
In simple terms: After the phosphate is removed, the product PI(4)P is released from the enzyme.
Once dephosphorylation is complete, the product phosphatidylinositol-4-phosphate [PI(4)P] is released from the active site. This release is thought to be driven by conformational changes in the enzyme that reduce its affinity for the product, allowing it to diffuse within the membrane or be further metabolized. The enzyme can then cycle back to bind another substrate molecule.
Regulation by voltage and other factors
In simple terms: Some enzymes with this activity are turned on or off by changes in membrane voltage.
Voltage-sensing phosphatases (VSPs) exhibit 3-phosphatase activity toward PI(3,4)P2 that is tightly regulated by membrane voltage. Studies in living cells have shown that both the 5-phosphatase and 3-phosphatase activities of VSP display identical voltage dependence, meaning that membrane depolarization simultaneously activates both activities. This unique regulation links electrical signaling to lipid metabolism.
Key Genes Involved in GO:0051800 phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
The following genes encode enzymes or regulators that directly or indirectly influence phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity and PI(3,4)P2 metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | Catalyzes the dephosphorylation of PI(3,4)P2 to PI(4)P; tumor suppressor | Most frequently mutated in cancers; key target for cancer research |
| INPP4B | Inositol polyphosphate 4-phosphatase; regulates PI(3,4)P2 levels | Associated with chemoresistance and poor outcome in AML |
| SHIP1 (INPP5D) | 5-phosphatase that converts PI(3,4,5)P3 to PI(3,4)P2 | Regulates PI3K effectors in T lymphocytes |
| SHIP2 (INPPL1) | 5-phosphatase that controls PI(3,4)P2 concentrations | Modulates insulin signaling and cytoskeletal dynamics |
| VSP (e.g., from Ciona intestinalis) | Voltage-sensing phosphatase with 3-phosphatase activity toward PI(3,4)P2 | Model for studying voltage-dependent lipid signaling [1,7] |
| PIK3CA | Catalytic subunit of class I PI3K; produces PI(3,4,5)P3 and PI(3,4)P2 | Oncogene frequently mutated in cancer |
| PIK3R1 | Regulatory subunit of class I PI3K | Modulates PI3K activity and downstream signaling |
| AKT1 | Serine/threonine kinase activated by PI(3,4)P2 and PI(3,4,5)P3 | Key effector of PI3K signaling; drug target |
| MTOR | Kinase in mTORC2 complex activated by PI3K signaling | Central regulator of cell growth and metabolism |
| PTENP1 | Pseudogene of PTEN; regulates PTEN expression | Potential ceRNA in cancer |
| INPP5A | Inositol polyphosphate 5-phosphatase | Modulates inositol phosphate signaling |
| INPP5B | Inositol polyphosphate 5-phosphatase | Involved in phosphoinositide metabolism |
| OCRL | Inositol polyphosphate 5-phosphatase | Mutated in Lowe syndrome |
| SYNJ1 | Synaptojanin 1; 5-phosphatase | Regulates synaptic vesicle recycling |
| FIG4 | Phosphoinositide 5-phosphatase | Mutated in Charcot-Marie-Tooth disease |
| MTM1 | Myotubularin; 3-phosphatase | Mutated in X-linked myotubular myopathy |
| MTMR2 | Myotubularin-related protein 2; 3-phosphatase | Mutated in Charcot-Marie-Tooth disease |
| TPTE2 | Transmembrane phosphatase with tensin homology | Potential tumor suppressor |
How Is phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity Regulated?
The activity of phosphatidylinositol-3,4-bisphosphate 3-phosphatase is regulated at multiple levels. PTEN, the primary enzyme, is controlled by phosphorylation, ubiquitination, and subcellular localization, which affect its catalytic activity and access to substrate. Membrane voltage regulates the 3-phosphatase activity of voltage-sensing phosphatases, as shown by identical voltage dependence of 5- and 3-phosphatase activities in living cells. Additionally, the levels of PI(3,4)P2 are influenced by the opposing actions of class I PI3Ks and 5-phosphatases such as SHIP1 and SHIP2, which produce PI(3,4)P2 from PI(3,4,5)P3 [2,6]. This complex interplay ensures tight control of phosphoinositide signaling.
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (e.g., glioblastoma, prostate, breast) | PTEN knockout cell lines and mouse models |
| INPP4B | Acute myeloid leukemia, chemoresistance | INPP4B knockout or overexpression in AML cell lines |
| SHIP1 | Immune disorders, leukemia | SHIP1 knockout mice and T cell lines |
| SHIP2 | Type 2 diabetes, insulin resistance | SHIP2 knockout mice and adipocytes |
| VSP | Neurological disorders (voltage-dependent signaling) | VSP-expressing cell lines for voltage-clamp studies [1,7] |
Cancer
Loss-of-function mutations in PTEN, which encodes the major enzyme with phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity, lead to accumulation of PI(3,4)P2 and hyperactivation of PI3K/Akt signaling, driving tumorigenesis in many cancers. INPP4B, another regulator of PI(3,4)P2, is associated with chemoresistance and poor prognosis in acute myeloid leukemia. Thus, dysregulation of this activity is a hallmark of cancer.
Immune disorders
SHIP1 and SHIP2, which modulate PI(3,4)P2 levels indirectly, play critical roles in immune cell signaling. SHIP1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and regulates novel PI3K effectors, and its dysfunction is linked to autoimmune and inflammatory conditions. SHIP2 controls PI(3,4)P2 concentrations, affecting insulin sensitivity and immune responses.
Neurological disorders
Voltage-sensing phosphatases, which exhibit 3-phosphatase activity toward PI(3,4)P2, are important for neuronal signaling. Their voltage-dependent regulation suggests a role in electrical activity-dependent lipid metabolism, and mutations in related phosphatases like MTM1 and MTMR2 cause X-linked myotubular myopathy and Charcot-Marie-Tooth disease, respectively [3,7].
From phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTEN increase PI(3,4)P2 levels? | PTEN knockout cell lines (e.g., HCT116, U87) |
| How does a specific PTEN mutation affect its 3-phosphatase activity? | Point mutation knock-in of PTEN (e.g., C124S, G129E) |
| What is the effect of INPP4B overexpression on chemoresistance? | INPP4B overexpression in AML cell lines |
| Does SHIP1 regulate PI(3,4)P2 in T cells? | SHIP1 knockout mice and Jurkat T cells |
| Can voltage-sensing phosphatase activity be optically controlled? | Knock-in of tagged VSP for live-cell imaging |
| What is the role of PI(3,4)P2 in class I PI3K signaling in vivo? | Transgenic mouse models expressing PI(3,4)P2 biosensors |
How to Study the phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry lipidomics | Levels of PI(3,4)P2 and PI(4)P | Quantifying lipid changes in knockout cells |
| Live-cell biosensor imaging | Real-time PI(3,4)P2 dynamics | Monitoring voltage-dependent lipid signaling [7,8] |
| In vitro phosphatase assay | Enzymatic release of phosphate from PI(3,4)P2 | Characterizing enzyme kinetics and specificity |
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Identifying regulators of PI(3,4)P2 metabolism |
| Western blotting | Protein expression and phosphorylation status | Validating PTEN loss and Akt activation |
| Immunofluorescence | Subcellular localization of enzymes | Studying membrane recruitment of PTEN |
| RNA-seq | Transcriptional changes upon pathway modulation | Assessing downstream effects of PI(3,4)P2 accumulation |
| Co-immunoprecipitation | Protein-protein interactions | Identifying binding partners of PTEN or INPP4B |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics allows direct quantification of PI(3,4)P2 and PI(4)P levels in cells and tissues. This method is essential to measure the enzymatic activity of phosphatidylinositol-3,4-bisphosphate 3-phosphatase in response to genetic or pharmacological perturbations.
Live-cell imaging with biosensors
Genetically encoded biosensors, such as GFP-tagged PH domains that specifically bind PI(3,4)P2, enable real-time visualization of this lipid in living cells. This approach has been used to monitor PI(3,4)P2 dynamics in transgenic mouse models and to study voltage-dependent regulation by VSPs [7,8].
In vitro phosphatase assays
Recombinant enzymes can be incubated with synthetic PI(3,4)P2 substrates, and the release of phosphate or the formation of PI(4)P can be measured using colorimetric or radioactive assays. Such assays have been used to characterize the 3-phosphatase activity of VSP and PTEN [1,4].
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes that modulate PI(3,4)P2 levels or sensitivity to PI3K inhibitors. These screens help uncover novel regulators of phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity and its downstream effects.
How CRISPR Can Be Used to Study GO:0051800 phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
Knockout
CRISPR knockout of PTEN or INPP4B in cell lines leads to accumulation of PI(3,4)P2 and activation of downstream Akt signaling, providing a robust model to study the consequences of losing phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [4,5]. Knockout models are essential for validating the role of these enzymes in cancer and metabolism.
Point Mutation
Introducing specific point mutations into the catalytic domain of PTEN (e.g., C124S, G129E) via CRISPR-mediated homology-directed repair allows researchers to dissect the contribution of the 3-phosphatase activity from other functions of PTEN, such as protein phosphatase activity. Such models are invaluable for understanding the precise role of GO:0051800 in disease.
Knock-in
Knock-in of tagged versions of PTEN or VSP (e.g., GFP or HaloTag) enables real-time tracking of enzyme localization and dynamics in living cells. This approach has been used to study the voltage-dependent membrane recruitment of VSP and its 3-phosphatase activity.
Overexpression
CRISPR-mediated overexpression of INPP4B or SHIP2 can be achieved by inserting a strong promoter or using CRISPR activation (CRISPRa). Overexpression models help determine whether increasing the activity of these enzymes can reverse PI3K-driven phenotypes, such as chemoresistance in leukemia.
How EDITGENE Supports phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity Research
Researchers studying phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. This requires precise genetic manipulation, which can be achieved through CRISPR-based cell model generation.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity research.
Frequently Asked Questions About phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
What is phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity?
It is the enzymatic activity that removes the 3-phosphate from PI(3,4)P2 to produce PI(4)P and phosphate, as defined by GO:0051800.
What genes are involved in phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity?
The primary gene is PTEN, but INPP4B, SHIP1, SHIP2, and voltage-sensing phosphatases also regulate PI(3,4)P2 levels [1,2,4,5,6].
What is the role of PTEN in PI(3,4)P2 signaling?
PTEN directly dephosphorylates PI(3,4)P2 to PI(4)P, thereby terminating PI3K signaling and suppressing tumor growth.
How is phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity regulated?
It is regulated by phosphorylation, ubiquitination, subcellular localization, and in some enzymes by membrane voltage [4,7].
What diseases are associated with defects in this activity?
Cancer, immune disorders, and neurological conditions are linked to dysregulation of PI(3,4)P2 metabolism [4,5,6].
What methods are used to study phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity?
Common methods include lipidomics, live-cell biosensor imaging, in vitro phosphatase assays, and CRISPR screening [1,4,7,8].
Can CRISPR be used to model mutations in PTEN?
Yes, CRISPR knock-in can introduce specific point mutations (e.g., C124S) to study the effects on 3-phosphatase activity.
What is the difference between PTEN and INPP4B?
PTEN is a 3-phosphatase that directly dephosphorylates PI(3,4)P2, while INPP4B is a 4-phosphatase that removes the 4-phosphate from PI(3,4)P2, producing PI(3)P [4,5].
How does SHIP2 affect PI(3,4)P2 levels?
SHIP2 is a 5-phosphatase that converts PI(3,4,5)P3 to PI(3,4)P2, thereby indirectly influencing the substrate available for 3-phosphatases.
Why is phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity important for cancer research?
Because loss of this activity leads to accumulation of PI(3,4)P2 and hyperactivation of oncogenic PI3K/Akt signaling, making it a key tumor suppressor mechanism.
Conclusion
Phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity (GO:0051800) is a fundamental enzymatic function that controls the cellular levels of PI(3,4)P2, a critical lipid second messenger. Through the action of PTEN and other enzymes, this activity acts as a brake on PI3K signaling, and its dysregulation is implicated in cancer, immune disorders, and neurological diseases. Continued research using advanced CRISPR models and lipidomics will further illuminate its therapeutic potential.
References
- 1. Kurokawa T et al.. 2012. 3' Phosphatase activity toward phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] by voltage-sensing phosphatase (VSP).. Proc Natl Acad Sci U S A 109(25):10089-94 PMID: 22645351
- 2. Batty IH et al.. 2007. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.. Biochem J 407(2):255-66 PMID: 17672824
- 3. Woscholski R et al.. 1995. Purification and biochemical characterization of a mammalian phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase.. J Biol Chem 270(52):31001-7 PMID: 8537357
- 4. Malek M et al.. 2017. PTEN Regulates PI(3,4)P(2) Signaling Downstream of Class I PI3K.. Mol Cell 68(3):566-580.e10 PMID: 29056325
- 5. Rijal S et al.. 2015. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.. Blood 125(18):2815-24 PMID: 25736313
- 6. Freeburn RW et al.. 2002. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.. J Immunol 169(10):5441-50 PMID: 12421919
- 7. Keum D et al.. 2016. Phosphoinositide 5- and 3-phosphatase activities of a voltage-sensing phosphatase in living cells show identical voltage dependence.. Proc Natl Acad Sci U S A 113(26):E3686-95 PMID: 27222577
- 8. Sasaki T et al.. 2007. Non-invasive visualization of the lipid product of class I PI3K in transgenic mouse models.. Biochem Soc Trans 35(Pt 2):215-8 PMID: 17371241
